Avatrombopag, a Novel Thrombopoietin Receptor Agonist, Increases Platelet Counts without Increasing Platelet Activation in Patients with Thrombocytopenia Due to Chronic Liver Disease

被引：0
|
作者：
Frelinger, Andrew L., III
Koganov, Elena Smolensky
Forde, Emma E.
Carmichael, Sabrina L.
Michelson, Alan D.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
290
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease
    Michelson, A. D.
    Koganov, E. Smolensky
    Forde, E. E.
    Carmichael, S. L.
    Frelinger, A. L., III
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (12) : 2515 - 2519
  • [2] Splenomegaly status does not impact the efficacy of avatrombopag in increasing platelet counts and reducing platelet transfusions or rescue procedures for bleeding in chronic liver disease patients with thrombocytopenia
    Qamar, Amir
    Aggarwal, Kavita
    Vredenburg, Michael
    Tian, Wei
    Allen, Lee F.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E690 - E690
  • [3] Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
    Terrault, Norah
    Chen, Yi-Cheng
    Izumi, Namiki
    Kayali, Zeid
    Mitrut, Paul
    Tak, Won Young
    Allen, Lee F.
    Hassanein, Tarek
    GASTROENTEROLOGY, 2018, 155 (03) : 705 - 718
  • [4] Thrombopoietin receptor agonist is more effective than platelet transfusion for chronic liver disease with thrombocytopenia, shown by propensity score matching
    Furuichi, Yoshihiro
    Takeuchi, Hirohito
    Yoshimasu, Yuu
    Kasai, Yoshitaka
    Abe, Masakazu
    Itoi, Takao
    HEPATOLOGY RESEARCH, 2020, 50 (09) : 1062 - 1070
  • [5] Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
    Jurczak, Wojciech
    Chojnowski, Krzysztof
    Mayer, Jiri
    Krawczyk, Katarzyna
    Jamieson, Brian D.
    Tian, Wei
    Allen, Lee F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 479 - 490
  • [6] EFFICACY OF AVATROMBOPAG IN OPTIMIZING PLATELET COUTNS IN PATIENTS WITH CHRONIC LIVER DISEASE AND THROMBOCYTOPENIA UNDERGOING GI PROCEDURES
    Brelvi, Zamir
    Allen, Lee F.
    Aggarwal, Kavita
    Vredenburg, Michael
    Tian, Wei
    Franklin, Howard
    GASTROENTEROLOGY, 2019, 156 (06) : S1336 - S1336
  • [7] SB-497115, a novel, oral, small molecule thrombopoietin receptor agonist, increases platelet counts in healthy subjects
    Jenkins, JM
    Williams, D
    Collins, DA
    Deng, Y
    Kitchen, V
    Erickson-Miller, C
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 64 - 65
  • [8] EFFECT OF THROMBOPOIETIN RECEPTOR AGONIST IS HIGHER THAN THAT OF PLATELET TRANSFUSION IN CHRONIC LIVER DISEASE WITH THROMBOCYTOPENIA -FROM PROPENSITY SCORE MATCHING-
    Furuichi, Yoshihiro
    Takeuchi, Hirohito
    Abe, Masakazu
    Kasai, Yoshitaka
    Itoi, Takao
    GASTROENTEROLOGY, 2019, 156 (06) : S113 - S113
  • [9] EFFECT OF THROMBOPOIETIN RECEPTOR AGONISTS ON COAGULATION AND PLATELET ACTIVATION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
    Garabet, L.
    Lee, S.
    Mowinckel, M. -C.
    Jonassen, C.
    Liebman, H.
    Bussel, J.
    Sandset, P. M.
    Ghanima, W.
    HAEMATOLOGICA, 2015, 100 : 568 - 568
  • [10] Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag
    Abdela, Jemal
    CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS, 2019, 12
12345